insurance changes glp-1 What You Need to Know About Coverage Weight Loss Drug Coverage |

Robert Kushner: Mike, a pleasure

Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig

However, that hasnt stopped many experts from advocating for GLP-1 drugs for this patient population, and physicians from prescribing them

49 Furthermore, the constitutive expression of claudin-1 in gut epithelium in mice resulted in decreased claudin-7 expression and enhanced susceptibility to acute colitis

Based on the available data, Orderly Meds falls somewhere in the middle of the spectrum on this metric